4
Changes in Ownership
Prelude Therapeutics Inc Filed Acc 0001562180-24-008532
CLO, Interim CFO, Corp Sec. bought 25,000 shares at $0.91 ($22,638)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lim Bryant David CLO, Interim CFO, Corp Sec. | 2024-12-19 | Purchase | +25,000 | $0.91 | $22,638 | 27,400 | D |
| Open-market purchases · 25,000 sh · avg $0.91 · $22,638 | |||||||
Loading xslF345X05/primarydocument.xml…